Skip to main content
Fig. 3 | BMC Public Health

Fig. 3

From: Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994–2012

Fig. 3

Kaplan-Meier survival analysis for participants (N = 329) showed a significant difference between sustained viremia (N = 154) survival trends from intermittent viremia (N = 95) and non-viremia (N = 80) HIV treatment careers using >80 copies/mL HIV RNA or lower at time of assay detection limit with (+) signs indicating censored observations and survival time defined as age at last visit seen alive minus age at first visit

Back to article page